Loading…
Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures
Moderate consumption of wine is associated with a reduced risk of cancer. Grape plant cell cultures were used to purify 12 phenols: the stilbenoids trans-astringin, trans-piceid (2), trans-resveratroloside, trans-resveratrol, trans-piceatannol, cis-resveratroloside, cis-piceid, and cis-resveratrol;...
Saved in:
Published in: | Nutrition and cancer 2001-01, Vol.40 (2), p.173-179 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c446t-5511c16c0c766a25fa21ad2abf1cdd0569aeeb549c51a68a605b0b5ac9a850e63 |
---|---|
cites | cdi_FETCH-LOGICAL-c446t-5511c16c0c766a25fa21ad2abf1cdd0569aeeb549c51a68a605b0b5ac9a850e63 |
container_end_page | 179 |
container_issue | 2 |
container_start_page | 173 |
container_title | Nutrition and cancer |
container_volume | 40 |
creator | Waffo-Téguo, Pierre Hawthorne, Michael E. Cuendet, Muriel Mérillon, Jean-Michel Kinghorn, A. Douglas Pezzuto, John M. Mehta, Rajendra G. |
description | Moderate consumption of wine is associated with a reduced risk of cancer. Grape plant cell cultures were used to purify 12 phenols: the stilbenoids trans-astringin, trans-piceid (2), trans-resveratroloside, trans-resveratrol, trans-piceatannol, cis-resveratroloside, cis-piceid, and cis-resveratrol; the flavans (+)-catechin, (-)-epicatechin, and epicatechin 3′-O-gallate; and the flavan dimer procyanidin B'2 3′-O-gallate. These compounds were evaluated for potential to inhibit cyclooxygenases and preneoplastic lesion formation in carcinogen-treated mouse mammary glands in organ culture. At 10 μg/ml, trans-astringin and trans-piceatannol inhibited development of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesions in mouse mammary glands with 68.8% and 76.9% inhibition, respectively, compared with untreated glands. The latter compound was the most potent of the 12 compounds tested in this assay, with the exception of trans-resveratrol (87.5% inhibition). In the cyclooxygenase (COX)-1 assay, trans isomers of the stilbenoids appear to be more active than cis isomers: trans-resveratrol [50% inhibitory concentration (IC
50
50) = 14.9 μM, 96%] vs. cis-resveratrol (IC
50
= 55.4 μM). In the COX-2 assay, among the compounds tested, only trans- and cis-resveratrol exhibited significant inhibitory activity (IC
50
= 32.2 and 50.2 μM, respectively). This is the first report showing the potential cancer-chemopreventive activity of trans-astringin, a plant stilbenoid recently found in wine. trans-Astringin and its aglycone trans-piceatannol were active in the mouse mammary gland organ culture assay but did not exhibit activity in COX-1 and COX-2 assays. trans-Resveratrol was active in all three of the bioassays used in this investigation. These findings suggest that trans-astringin and trans-piceatannol may function as potential cancer-chemopreventive agents by a mechanism different from that of trans-resveratrol. |
doi_str_mv | 10.1207/S15327914NC402_14 |
format | article |
fullrecord | <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_13587393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11962253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-5511c16c0c766a25fa21ad2abf1cdd0569aeeb549c51a68a605b0b5ac9a850e63</originalsourceid><addsrcrecordid>eNp1kMFO3DAQhq0KVBbaB-gF-VIJDgFPEjuJ1MsqAloJQSWgPUYTZyKMnHhle7fl1Fdvol3EAXEa6df3ecY_Y19AnEEqivM7kFlaVJDf1LlIG8g_sMUcJXO2xxYCVJZIWcIBOwzhSQhRQFZ-ZAcAlUpTmS3Yv58u0hgNWl7jqMkn9SMNbuVpM8cb4ks9DRMNBe56_tuMxO-isS2NznSB49jxS4sbHAO_-Bs96khT4t3ArzyuiJ_8muTAN2Y0PXk85TXZadnaxrWn8Int92gDfd7NI_ZweXFff0-ub69-1MvrROe5itMnADQoLXShFKayxxSwS7HtQXedkKpColbmlZaAqkQlZCtaibrCUgpS2RGD7bvauxA89c3KmwH9cwOimcts3pQ5OcdbZ7VuB-pejV17E_B1B2DQaHs_NWjCK5fJssiqmfu25czYOz_gH-dt10R8ts6_SNn7d_wHwiCR8g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Waffo-Téguo, Pierre ; Hawthorne, Michael E. ; Cuendet, Muriel ; Mérillon, Jean-Michel ; Kinghorn, A. Douglas ; Pezzuto, John M. ; Mehta, Rajendra G.</creator><creatorcontrib>Waffo-Téguo, Pierre ; Hawthorne, Michael E. ; Cuendet, Muriel ; Mérillon, Jean-Michel ; Kinghorn, A. Douglas ; Pezzuto, John M. ; Mehta, Rajendra G.</creatorcontrib><description>Moderate consumption of wine is associated with a reduced risk of cancer. Grape plant cell cultures were used to purify 12 phenols: the stilbenoids trans-astringin, trans-piceid (2), trans-resveratroloside, trans-resveratrol, trans-piceatannol, cis-resveratroloside, cis-piceid, and cis-resveratrol; the flavans (+)-catechin, (-)-epicatechin, and epicatechin 3′-O-gallate; and the flavan dimer procyanidin B'2 3′-O-gallate. These compounds were evaluated for potential to inhibit cyclooxygenases and preneoplastic lesion formation in carcinogen-treated mouse mammary glands in organ culture. At 10 μg/ml, trans-astringin and trans-piceatannol inhibited development of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesions in mouse mammary glands with 68.8% and 76.9% inhibition, respectively, compared with untreated glands. The latter compound was the most potent of the 12 compounds tested in this assay, with the exception of trans-resveratrol (87.5% inhibition). In the cyclooxygenase (COX)-1 assay, trans isomers of the stilbenoids appear to be more active than cis isomers: trans-resveratrol [50% inhibitory concentration (IC
50
50) = 14.9 μM, 96%] vs. cis-resveratrol (IC
50
= 55.4 μM). In the COX-2 assay, among the compounds tested, only trans- and cis-resveratrol exhibited significant inhibitory activity (IC
50
= 32.2 and 50.2 μM, respectively). This is the first report showing the potential cancer-chemopreventive activity of trans-astringin, a plant stilbenoid recently found in wine. trans-Astringin and its aglycone trans-piceatannol were active in the mouse mammary gland organ culture assay but did not exhibit activity in COX-1 and COX-2 assays. trans-Resveratrol was active in all three of the bioassays used in this investigation. These findings suggest that trans-astringin and trans-piceatannol may function as potential cancer-chemopreventive agents by a mechanism different from that of trans-resveratrol.</description><identifier>ISSN: 0163-5581</identifier><identifier>EISSN: 1532-7914</identifier><identifier>DOI: 10.1207/S15327914NC402_14</identifier><identifier>PMID: 11962253</identifier><identifier>CODEN: NUCADQ</identifier><language>eng</language><publisher>Philadelphia, PA: Lawrence Erlbaum Associates, Inc</publisher><subject>9,10-Dimethyl-1,2-benzanthracene ; Animals ; Anticarcinogenic Agents - pharmacology ; Anticarcinogenic Agents - therapeutic use ; Biflavonoids ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; Catechin - analogs & derivatives ; Catechin - pharmacology ; Catechin - therapeutic use ; Cells, Cultured ; Chromatography, High Pressure Liquid ; Cyclooxygenase 1 ; Cyclooxygenase 2 ; Cyclooxygenase 2 Inhibitors ; Cyclooxygenase Inhibitors - pharmacology ; Female ; Foods and miscellaneous ; Isoenzymes - antagonists & inhibitors ; Isoenzymes - metabolism ; Mammary Neoplasms, Experimental - chemically induced ; Mammary Neoplasms, Experimental - prevention & control ; Medical sciences ; Membrane Proteins ; Mice ; Mice, Inbred BALB C ; Organ Culture Techniques ; Oxygen Consumption ; Phenols - isolation & purification ; Plant Extracts - chemistry ; Proanthocyanidins ; Prostaglandin-Endoperoxide Synthases - metabolism ; Stilbenes - pharmacology ; Stilbenes - therapeutic use ; Tumors ; Vitis - chemistry ; Wine - analysis</subject><ispartof>Nutrition and cancer, 2001-01, Vol.40 (2), p.173-179</ispartof><rights>Copyright Taylor & Francis Group, LLC 2001</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-5511c16c0c766a25fa21ad2abf1cdd0569aeeb549c51a68a605b0b5ac9a850e63</citedby><cites>FETCH-LOGICAL-c446t-5511c16c0c766a25fa21ad2abf1cdd0569aeeb549c51a68a605b0b5ac9a850e63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13587393$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11962253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waffo-Téguo, Pierre</creatorcontrib><creatorcontrib>Hawthorne, Michael E.</creatorcontrib><creatorcontrib>Cuendet, Muriel</creatorcontrib><creatorcontrib>Mérillon, Jean-Michel</creatorcontrib><creatorcontrib>Kinghorn, A. Douglas</creatorcontrib><creatorcontrib>Pezzuto, John M.</creatorcontrib><creatorcontrib>Mehta, Rajendra G.</creatorcontrib><title>Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures</title><title>Nutrition and cancer</title><addtitle>Nutr Cancer</addtitle><description>Moderate consumption of wine is associated with a reduced risk of cancer. Grape plant cell cultures were used to purify 12 phenols: the stilbenoids trans-astringin, trans-piceid (2), trans-resveratroloside, trans-resveratrol, trans-piceatannol, cis-resveratroloside, cis-piceid, and cis-resveratrol; the flavans (+)-catechin, (-)-epicatechin, and epicatechin 3′-O-gallate; and the flavan dimer procyanidin B'2 3′-O-gallate. These compounds were evaluated for potential to inhibit cyclooxygenases and preneoplastic lesion formation in carcinogen-treated mouse mammary glands in organ culture. At 10 μg/ml, trans-astringin and trans-piceatannol inhibited development of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesions in mouse mammary glands with 68.8% and 76.9% inhibition, respectively, compared with untreated glands. The latter compound was the most potent of the 12 compounds tested in this assay, with the exception of trans-resveratrol (87.5% inhibition). In the cyclooxygenase (COX)-1 assay, trans isomers of the stilbenoids appear to be more active than cis isomers: trans-resveratrol [50% inhibitory concentration (IC
50
50) = 14.9 μM, 96%] vs. cis-resveratrol (IC
50
= 55.4 μM). In the COX-2 assay, among the compounds tested, only trans- and cis-resveratrol exhibited significant inhibitory activity (IC
50
= 32.2 and 50.2 μM, respectively). This is the first report showing the potential cancer-chemopreventive activity of trans-astringin, a plant stilbenoid recently found in wine. trans-Astringin and its aglycone trans-piceatannol were active in the mouse mammary gland organ culture assay but did not exhibit activity in COX-1 and COX-2 assays. trans-Resveratrol was active in all three of the bioassays used in this investigation. These findings suggest that trans-astringin and trans-piceatannol may function as potential cancer-chemopreventive agents by a mechanism different from that of trans-resveratrol.</description><subject>9,10-Dimethyl-1,2-benzanthracene</subject><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>Anticarcinogenic Agents - therapeutic use</subject><subject>Biflavonoids</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Catechin - analogs & derivatives</subject><subject>Catechin - pharmacology</subject><subject>Catechin - therapeutic use</subject><subject>Cells, Cultured</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cyclooxygenase 1</subject><subject>Cyclooxygenase 2</subject><subject>Cyclooxygenase 2 Inhibitors</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Female</subject><subject>Foods and miscellaneous</subject><subject>Isoenzymes - antagonists & inhibitors</subject><subject>Isoenzymes - metabolism</subject><subject>Mammary Neoplasms, Experimental - chemically induced</subject><subject>Mammary Neoplasms, Experimental - prevention & control</subject><subject>Medical sciences</subject><subject>Membrane Proteins</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Organ Culture Techniques</subject><subject>Oxygen Consumption</subject><subject>Phenols - isolation & purification</subject><subject>Plant Extracts - chemistry</subject><subject>Proanthocyanidins</subject><subject>Prostaglandin-Endoperoxide Synthases - metabolism</subject><subject>Stilbenes - pharmacology</subject><subject>Stilbenes - therapeutic use</subject><subject>Tumors</subject><subject>Vitis - chemistry</subject><subject>Wine - analysis</subject><issn>0163-5581</issn><issn>1532-7914</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kMFO3DAQhq0KVBbaB-gF-VIJDgFPEjuJ1MsqAloJQSWgPUYTZyKMnHhle7fl1Fdvol3EAXEa6df3ecY_Y19AnEEqivM7kFlaVJDf1LlIG8g_sMUcJXO2xxYCVJZIWcIBOwzhSQhRQFZ-ZAcAlUpTmS3Yv58u0hgNWl7jqMkn9SMNbuVpM8cb4ks9DRMNBe56_tuMxO-isS2NznSB49jxS4sbHAO_-Bs96khT4t3ArzyuiJ_8muTAN2Y0PXk85TXZadnaxrWn8Int92gDfd7NI_ZweXFff0-ub69-1MvrROe5itMnADQoLXShFKayxxSwS7HtQXedkKpColbmlZaAqkQlZCtaibrCUgpS2RGD7bvauxA89c3KmwH9cwOimcts3pQ5OcdbZ7VuB-pejV17E_B1B2DQaHs_NWjCK5fJssiqmfu25czYOz_gH-dt10R8ts6_SNn7d_wHwiCR8g</recordid><startdate>20010101</startdate><enddate>20010101</enddate><creator>Waffo-Téguo, Pierre</creator><creator>Hawthorne, Michael E.</creator><creator>Cuendet, Muriel</creator><creator>Mérillon, Jean-Michel</creator><creator>Kinghorn, A. Douglas</creator><creator>Pezzuto, John M.</creator><creator>Mehta, Rajendra G.</creator><general>Lawrence Erlbaum Associates, Inc</general><general>Taylor& Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010101</creationdate><title>Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures</title><author>Waffo-Téguo, Pierre ; Hawthorne, Michael E. ; Cuendet, Muriel ; Mérillon, Jean-Michel ; Kinghorn, A. Douglas ; Pezzuto, John M. ; Mehta, Rajendra G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-5511c16c0c766a25fa21ad2abf1cdd0569aeeb549c51a68a605b0b5ac9a850e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>9,10-Dimethyl-1,2-benzanthracene</topic><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>Anticarcinogenic Agents - therapeutic use</topic><topic>Biflavonoids</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Catechin - analogs & derivatives</topic><topic>Catechin - pharmacology</topic><topic>Catechin - therapeutic use</topic><topic>Cells, Cultured</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cyclooxygenase 1</topic><topic>Cyclooxygenase 2</topic><topic>Cyclooxygenase 2 Inhibitors</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Female</topic><topic>Foods and miscellaneous</topic><topic>Isoenzymes - antagonists & inhibitors</topic><topic>Isoenzymes - metabolism</topic><topic>Mammary Neoplasms, Experimental - chemically induced</topic><topic>Mammary Neoplasms, Experimental - prevention & control</topic><topic>Medical sciences</topic><topic>Membrane Proteins</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Organ Culture Techniques</topic><topic>Oxygen Consumption</topic><topic>Phenols - isolation & purification</topic><topic>Plant Extracts - chemistry</topic><topic>Proanthocyanidins</topic><topic>Prostaglandin-Endoperoxide Synthases - metabolism</topic><topic>Stilbenes - pharmacology</topic><topic>Stilbenes - therapeutic use</topic><topic>Tumors</topic><topic>Vitis - chemistry</topic><topic>Wine - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waffo-Téguo, Pierre</creatorcontrib><creatorcontrib>Hawthorne, Michael E.</creatorcontrib><creatorcontrib>Cuendet, Muriel</creatorcontrib><creatorcontrib>Mérillon, Jean-Michel</creatorcontrib><creatorcontrib>Kinghorn, A. Douglas</creatorcontrib><creatorcontrib>Pezzuto, John M.</creatorcontrib><creatorcontrib>Mehta, Rajendra G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nutrition and cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waffo-Téguo, Pierre</au><au>Hawthorne, Michael E.</au><au>Cuendet, Muriel</au><au>Mérillon, Jean-Michel</au><au>Kinghorn, A. Douglas</au><au>Pezzuto, John M.</au><au>Mehta, Rajendra G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures</atitle><jtitle>Nutrition and cancer</jtitle><addtitle>Nutr Cancer</addtitle><date>2001-01-01</date><risdate>2001</risdate><volume>40</volume><issue>2</issue><spage>173</spage><epage>179</epage><pages>173-179</pages><issn>0163-5581</issn><eissn>1532-7914</eissn><coden>NUCADQ</coden><abstract>Moderate consumption of wine is associated with a reduced risk of cancer. Grape plant cell cultures were used to purify 12 phenols: the stilbenoids trans-astringin, trans-piceid (2), trans-resveratroloside, trans-resveratrol, trans-piceatannol, cis-resveratroloside, cis-piceid, and cis-resveratrol; the flavans (+)-catechin, (-)-epicatechin, and epicatechin 3′-O-gallate; and the flavan dimer procyanidin B'2 3′-O-gallate. These compounds were evaluated for potential to inhibit cyclooxygenases and preneoplastic lesion formation in carcinogen-treated mouse mammary glands in organ culture. At 10 μg/ml, trans-astringin and trans-piceatannol inhibited development of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesions in mouse mammary glands with 68.8% and 76.9% inhibition, respectively, compared with untreated glands. The latter compound was the most potent of the 12 compounds tested in this assay, with the exception of trans-resveratrol (87.5% inhibition). In the cyclooxygenase (COX)-1 assay, trans isomers of the stilbenoids appear to be more active than cis isomers: trans-resveratrol [50% inhibitory concentration (IC
50
50) = 14.9 μM, 96%] vs. cis-resveratrol (IC
50
= 55.4 μM). In the COX-2 assay, among the compounds tested, only trans- and cis-resveratrol exhibited significant inhibitory activity (IC
50
= 32.2 and 50.2 μM, respectively). This is the first report showing the potential cancer-chemopreventive activity of trans-astringin, a plant stilbenoid recently found in wine. trans-Astringin and its aglycone trans-piceatannol were active in the mouse mammary gland organ culture assay but did not exhibit activity in COX-1 and COX-2 assays. trans-Resveratrol was active in all three of the bioassays used in this investigation. These findings suggest that trans-astringin and trans-piceatannol may function as potential cancer-chemopreventive agents by a mechanism different from that of trans-resveratrol.</abstract><cop>Philadelphia, PA</cop><pub>Lawrence Erlbaum Associates, Inc</pub><pmid>11962253</pmid><doi>10.1207/S15327914NC402_14</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-5581 |
ispartof | Nutrition and cancer, 2001-01, Vol.40 (2), p.173-179 |
issn | 0163-5581 1532-7914 |
language | eng |
recordid | cdi_pascalfrancis_primary_13587393 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | 9,10-Dimethyl-1,2-benzanthracene Animals Anticarcinogenic Agents - pharmacology Anticarcinogenic Agents - therapeutic use Biflavonoids Biological and medical sciences Carcinogenesis, carcinogens and anticarcinogens Catechin - analogs & derivatives Catechin - pharmacology Catechin - therapeutic use Cells, Cultured Chromatography, High Pressure Liquid Cyclooxygenase 1 Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors - pharmacology Female Foods and miscellaneous Isoenzymes - antagonists & inhibitors Isoenzymes - metabolism Mammary Neoplasms, Experimental - chemically induced Mammary Neoplasms, Experimental - prevention & control Medical sciences Membrane Proteins Mice Mice, Inbred BALB C Organ Culture Techniques Oxygen Consumption Phenols - isolation & purification Plant Extracts - chemistry Proanthocyanidins Prostaglandin-Endoperoxide Synthases - metabolism Stilbenes - pharmacology Stilbenes - therapeutic use Tumors Vitis - chemistry Wine - analysis |
title | Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A41%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20Cancer-Chemopreventive%20Activities%20of%20Wine%20Stilbenoids%20and%20Flavans%20Extracted%20From%20Grape%20(Vitis%20vinifera)%20Cell%20Cultures&rft.jtitle=Nutrition%20and%20cancer&rft.au=Waffo-T%C3%A9guo,%20Pierre&rft.date=2001-01-01&rft.volume=40&rft.issue=2&rft.spage=173&rft.epage=179&rft.pages=173-179&rft.issn=0163-5581&rft.eissn=1532-7914&rft.coden=NUCADQ&rft_id=info:doi/10.1207/S15327914NC402_14&rft_dat=%3Cpubmed_pasca%3E11962253%3C/pubmed_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c446t-5511c16c0c766a25fa21ad2abf1cdd0569aeeb549c51a68a605b0b5ac9a850e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11962253&rfr_iscdi=true |